Jim Simons Lantern Pharma Inc. Call Options Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
37Shares Held
2.22MCall Options Held
16.4KPut Options Held
0-
Bios Capital Management, LP Fort Worth, TX1.08MShares$4.71 Million4.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.59 Million0.0% of portfolio
-
Cm Management, LLC200KShares$876,0000.65% of portfolio
-
Geode Capital Management, LLC Boston, MA91.9KShares$402,4820.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA56.5KShares$247,5000.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $47.4M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...